Industry Updates
This broad category includes articles concerning health insurance costs, carrier and health plan news, changing benefits technology, and surveys by the Kaiser Family Foundation and others on employee benefits.
Pharmacy retail chains staking their future on expanding the health care services they offer are running into a big problem: It’s getting harder to draw the next generation of pharmacists amid turmoil in the industry. Why it matters: The pharmacies’ ambitions to become go-to providers for vaccinations, patient monitoring and even prescribing are being threatened by workforce shortages and burnout, ...
The Federal Trade Commission has challenged the validity of over 100 drug product patents, focusing on devices used to deliver medicines, like inhalers and autoinjectors, in an effort to increase competition and potentially lower some prices.
When Kristy Uddin, 49, went in for her annual mammogram last year, she assumed she would not incur a bill because the test is one of the many preventive measures guaranteed to be free to patients under the 2010 Affordable Care Act.
Pharmaceutical companies are due to receive by Thursday the U.S. government's opening proposal for what are expected to be significant discounts on 10 of its high-cost medicines, an important step in the Medicare health program's first ever price negotiations.
The CEOs of Merck and Johnson & Johnson have voluntarily agreed to testify at an upcoming Senate hearing on high drug prices in the U.S., Sen. Bernie Sanders announced Friday, as lawmakers ramp up efforts to rein in health-care costs for Americans.
The resources serve as a “step forward” as the agency looks to propose enforceable standards, HHS Deputy Secretary Andrea Palm said in a statement.
More than 21.3 million people will be enrolled in an Affordable Care Act during this year’s open enrollment period, Centers for Medicare & Medicaid Services (CMS) announced today. Almost five million more people have signed up for a plan this year than last year, with open enrollment set to continue through the end of January ...
The specialty pharmacy could be valued at more than $4 billion in a sale, but a deal might slow the U.S. Healthcare segment’s drive toward profitability.
After she was diagnosed at age 48 with Type 1 diabetes, Stacey Silverman muddled through her days with high blood sugar, fatigue and splitting headaches. Taking a long-acting form of insulin called Levemir, one of many types of the hormone on the market, resolved those blood sugar swings. Now the 55-year-old Dallas-area resident worries her ...
Self-insured employers are set to face plenty of challenges this year, ranging from addressing the mental health needs of their workforces to developing strategies for on-site clinics amid a pivot to larger volumes of remote work.